HuffPost is part of Verizon Media. Click 'I agree' to allow Verizon Media and our partners to use cookies and similar technologies to access your device and use your data (including location) to understand your interests, and provide and measure personalised ads. We will also provide you with personalised ads on partner products. Learn more…
Harry Maguire celebrates his goal for Manchester United on Saturday (Getty). Ole Gunnar Solskjaer believes Manchester United's strength in depth will be crucial to their bid to win the FA Cup after they moved into the semi-finals with a 2-1 win over 10-man Norwich on Saturday.AS IT HAPPENED: Norwich 1-2 Manchester UnitedSolskjaer's side had to…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f